PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
+2.96%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$460M
AUM Growth
+$84.2M
(+22%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
22.41%
Top 10 Holdings %
Top 10 Hldgs %
34.98%
Holding
99
New
18
Increased
56
Reduced
8
Closed
16
Top Buys
| 1 |
Cooper Companies
COO
|
$15.8M |
| 2 |
Neurocrine Biosciences
NBIX
|
$10.3M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$10.2M |
| 4 |
Becton Dickinson
BDX
|
$9.85M |
| 5 |
Zimmer Biomet
ZBH
|
$8.4M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$14.7M |
| 2 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$7.03M |
| 3 |
Danaher
DHR
|
$5.84M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$4.6M |
| 5 |
Sarepta Therapeutics
SRPT
|
$4.58M |
Sector Composition
| 1 | Healthcare | 99.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Veracyte
VCYT
$2.43B
| $2.65M | 0.58% |
118,622
+896
| +0.8% | +$20K |
|
52
X4 Pharmaceuticals
XFOR
$80.1M
| $2.43M | 0.53% |
93,238
+14,053
| +18% | +$367K |
|
|
ISEE
53
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $2.36M | 0.51% |
97,082
+23,124
| +31% | +$563K |
|
54
Legend Biotech
LEGN
$6.41B
| $2.3M | 0.5% |
47,608
-44,324
| -48% | -$2.14M |
|
55
Liquidia Corp
LQDA
$2.45B
| $2.26M | 0.49% |
326,965
+57,773
| +21% | +$399K |
|
56
Axogen
AXGN
$722M
| $2.11M | 0.46% |
223,783
+33,728
| +18% | +$319K |
|
57
Cogent Biosciences
COGT
$1.8B
| $1.96M | 0.43% |
181,896
+40,314
| +28% | +$435K |
|
58
Procept Biorobotics
PRCT
$2.11B
| $1.91M | 0.42% |
67,252
-45,066
| -40% | -$1.28M |
|
59
Arcus Biosciences
RCUS
$1.22B
| $1.88M | 0.41% |
102,987
+15,527
| +18% | +$283K |
|
60
Cullinan Oncology
CGEM
$414M
| $1.74M | 0.38% |
169,886
+38,508
| +29% | +$394K |
|
|
MRNS
61
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.73M | 0.38% |
+250,000
| New | +$1.73M |
|
62
Establishment Labs
ESTA
$1.12B
| $1.69M | 0.37% |
+25,000
| New | +$1.69M |
|
63
Apellis Pharmaceuticals
APLS
$3.48B
| $1.65M | 0.36% |
+25,000
| New | +$1.65M |
|
|
AKYA
64
DELISTED
Akoya BioSciences
AKYA
| $1.65M | 0.36% |
201,385
+60,130
| +43% | +$492K |
|
65
Lexicon Pharmaceuticals
LXRX
$378M
| $1.64M | 0.36% |
675,328
+254,126
| +60% | +$618K |
|
66
NewAmsterdam Pharma
NAMS
$2.78B
| $1.52M | 0.33% |
+115,000
| New | +$1.52M |
|
67
Mirum Pharmaceuticals
MIRM
$3.71B
| $1.49M | 0.32% |
62,118
+9,364
| +18% | +$225K |
|
68
TELA Bio
TELA
$63.4M
| $1.46M | 0.32% |
137,372
+20,704
| +18% | +$220K |
|
|
GRTX
69
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $1.34M | 0.29% |
+525,000
| New | +$1.34M |
|
70
Aclaris Therapeutics
ACRS
$221M
| $1.34M | 0.29% |
166,020
-81,139
| -33% | -$656K |
|
|
SAGE
71
DELISTED
Sage Therapeutics
SAGE
| $1.06M | 0.23% |
+25,321
| New | +$1.06M |
|
|
SLN
72
Silence Therapeutics
SLN
$248M
| $984K | 0.21% |
158,774
+23,932
| +18% | +$148K |
|
73
Terns Pharmaceuticals
TERN
$597M
| $888K | 0.19% |
+75,000
| New | +$888K |
|
74
Cidara Therapeutics
CDTX
$1.62B
| $762K | 0.17% |
+30,000
| New | +$762K |
|
|
INZY
75
DELISTED
Inozyme Pharma
INZY
| $716K | 0.16% |
+125,000
| New | +$716K |
|